1. Home
  2. ON vs NTRA Comparison

ON vs NTRA Comparison

Compare ON & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ON Semiconductor Corporation

ON

ON Semiconductor Corporation

HOLD

Current Price

$83.99

Market Cap

43.9B

Sector

Technology

ML Signal

HOLD

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$311.74

Market Cap

39.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ON
NTRA
Founded
1992
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.9B
39.1B
IPO Year
2000
2015

Fundamental Metrics

Financial Performance
Metric
ON
NTRA
Price
$83.99
$311.74
Analyst Decision
Buy
Strong Buy
Analyst Count
25
15
Target Price
$65.29
$259.07
AVG Volume (30 Days)
9.9M
1.2M
Earning Date
05-04-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
0.65
EPS
0.48
N/A
Revenue
$5,878,300,000.00
$210,939,000.00
Revenue This Year
$7.93
$18.08
Revenue Next Year
$8.90
$19.65
P/E Ratio
$173.58
N/A
Revenue Growth
N/A
N/A
52 Week Low
$44.56
$156.71
52 Week High
$134.92
$326.03

Technical Indicators

Market Signals
Indicator
ON
NTRA
Relative Strength Index (RSI) 46.11 66.96
Support Level $54.93 $186.96
Resistance Level $102.64 N/A
Average True Range (ATR) 3.78 11.58
MACD 0.96 4.40
Stochastic Oscillator 60.16 82.27

Price Performance

Historical Comparison
ON
NTRA

About ON ON Semiconductor Corporation

Onsemi is a supplier of power semiconductors and sensors focused on the automotive and industrial markets. Onsemi is the second-largest power chipmaker in the world and the largest supplier of image sensors to the automotive market. While the firm used to be highly vertically integrated, it now pursues a hybrid manufacturing strategy for flexible capacity. Onsemi is pivoting to focus on emerging applications like electric vehicles, autonomous vehicles, industrial automation, and renewable energy.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: